IRCT2016070723640N5已完成3 期
Comparative evalution of Cimifugol and Salvigol effect on hot flash ,night sweating in menopausal women
Vice chancellor for research, Hamadan University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40 years 至 60 years（—）
- 性别
- Female
入选标准
- •At least one year after the last amenorrhea; lack of acute and chronic diseases with the approval of physician; not taking any herbal remedy from 3 months before the intervention; no previous allergy to herbal drugs. Exclusion criteria: having breast and genital cancer or a history of having them in the past; experiencing acute and chronic diseases during the study; lack of proper use of drugs during the study; medical allergy.
排除标准
- 未提供
研究者
相似试验
招募中
3 期
Comparison of the effect of Agnugol, Cimifugol , Soyagol , vitagnus and EsCitalopramMenopause.Menopausal and female climacteric statesN95.1IRCT20080902001181N4Esfahan University of Medical Sciences200
进行中（未招募）
1 期
Efficacy and safety of semaglutide versus canagliflozin as add-on to metformin in subjects with type 2 diabetesMedDRA version: 20.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861Diabetes Mellitus, Type 2EUCTR2016-000989-35-GBovo Nordisk A/S788
进行中（未招募）
3 期
The aim of the trial is to compare the effect of once-weekly (OW) dosing of subcutaneous semaglutide (1.0 mg) versus once-daily dosing of oral canagliflozin (300 mg) on glycaemic control in subjects with type 2 diabetes (T2D) on a background treatment of metformiCTRI/2017/07/009081ovo Nordisk India Private Ltd50
进行中（未招募）
1 期
Efficacy and safety of semaglutide versus canagliflozin as add-on to metformin in subjects with type 2 diabetesDiabetes Mellitus, Type 2EUCTR2016-000989-35-SEovo Nordisk A/S788
进行中（未招募）
1 期
Efficacy and safety of semaglutide versus canagliflozin as add-on to metformin in subjects with type 2 diabetesMedDRA version: 19.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861Diabetes Mellitus, Type 2EUCTR2016-000989-35-IEovo Nordisk A/S784